.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Queensland Health
Johnson and Johnson
Harvard Business School
McKesson
Medtronic
Daiichi Sankyo
Chubb
Julphar

Generated: December 18, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 9221220

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-001Aug 29, 2012RXYesNo► Subscribe► SubscribeY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-002Aug 29, 2012RXYesNo► Subscribe► SubscribeY
Novartis PharmAFINITOR DISPERZeverolimusTABLET, FOR SUSPENSION;ORAL203985-003Aug 29, 2012RXYesYes► Subscribe► SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-003Jul 9, 2010RXYesNo► Subscribe► SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-001Mar 30, 2009RXYesNo► Subscribe► SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-004Mar 30, 2012RXYesNo► Subscribe► SubscribeY
NovartisAFINITOReverolimusTABLET;ORAL022334-002Mar 30, 2009RXYesYes► Subscribe► SubscribeY
NovartisZORTRESSeverolimusTABLET;ORAL021560-001Apr 20, 2010RXYesNo► Subscribe► SubscribeY
NovartisZORTRESSeverolimusTABLET;ORAL021560-002Apr 20, 2010RXYesNo► Subscribe► SubscribeY
NovartisZORTRESSeverolimusTABLET;ORAL021560-003Apr 20, 2010RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist